 | • レポートコード：GIR-107A12212 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、糖尿病治療・ドラッグデリバリーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。糖尿病治療・ドラッグデリバリーの種類別市場規模（吸入可能インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓）、用途別市場規模（診断/クリニック、ICU、在宅ケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・糖尿病治療・ドラッグデリバリーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Medtronic、Sanofi、Novo Nordisk、MannKind、Enteris BioPharma、Dexcom、Senseonics Holding、Medtech、Johnson & Johnson、Synertech、Zosano Pharma、Relmada Therapeutics、Eli Lilly、Transdermal Specialties ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：吸入可能インスリン、経口インスリン、インスリンパッチ、CGMシステム、人工膵臓 ・用途別分析2016年-2026年：診断/クリニック、ICU、在宅ケア ・糖尿病治療・ドラッグデリバリーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・糖尿病治療・ドラッグデリバリーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・糖尿病治療・ドラッグデリバリーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・糖尿病治療・ドラッグデリバリーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・糖尿病治療・ドラッグデリバリーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Diabetes Therapy and Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Diabetes Therapy and Drug Delivery size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Diabetes Therapy and Drug Delivery market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Diabetes Therapy and Drug Delivery market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Inhalable Insulin
Oral Insulin
Insulin Patches
CGM Systems
Artificial Pancreas
Market segment by Application, can be divided into
Diagnostic/Clinics
ICUs
Home Healthcare
Market segment by players, this report covers
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind
Enteris BioPharma
Dexcom
Senseonics Holding
Medtech
Johnson & Johnson
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly
Transdermal Specialties
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Diabetes Therapy and Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Diabetes Therapy and Drug Delivery, with revenue, gross margin and global market share of Diabetes Therapy and Drug Delivery from 2019 to 2021.
Chapter 3, the Diabetes Therapy and Drug Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Diabetes Therapy and Drug Delivery market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Diabetes Therapy and Drug Delivery research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Diabetes Therapy and Drug Delivery
1.2 Classification of Diabetes Therapy and Drug Delivery by Type
1.2.1 Overview: Global Diabetes Therapy and Drug Delivery Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type in 2020
1.2.3 Inhalable Insulin
1.2.4 Oral Insulin
1.2.5 Insulin Patches
1.2.6 CGM Systems
1.2.7 Artificial Pancreas
1.3 Global Diabetes Therapy and Drug Delivery Market by Application
1.3.1 Overview: Global Diabetes Therapy and Drug Delivery Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Global Diabetes Therapy and Drug Delivery Market Size & Forecast
1.5 Global Diabetes Therapy and Drug Delivery Market Size and Forecast by Region
1.5.1 Global Diabetes Therapy and Drug Delivery Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Diabetes Therapy and Drug Delivery Market Size by Region, (2016-2021)
1.5.3 North America Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.4 Europe Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.6 South America Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Diabetes Therapy and Drug Delivery Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Diabetes Therapy and Drug Delivery Market Drivers
1.6.2 Diabetes Therapy and Drug Delivery Market Restraints
1.6.3 Diabetes Therapy and Drug Delivery Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Diabetes Therapy and Drug Delivery Product and Solutions
2.1.4 Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Diabetes Therapy and Drug Delivery Product and Solutions
2.2.4 Medtronic Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Medtronic Recent Developments and Future Plans
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi Diabetes Therapy and Drug Delivery Product and Solutions
2.3.4 Sanofi Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Sanofi Recent Developments and Future Plans
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business
2.4.3 Novo Nordisk Diabetes Therapy and Drug Delivery Product and Solutions
2.4.4 Novo Nordisk Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Novo Nordisk Recent Developments and Future Plans
2.5 MannKind
2.5.1 MannKind Details
2.5.2 MannKind Major Business
2.5.3 MannKind Diabetes Therapy and Drug Delivery Product and Solutions
2.5.4 MannKind Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 MannKind Recent Developments and Future Plans
2.6 Enteris BioPharma
2.6.1 Enteris BioPharma Details
2.6.2 Enteris BioPharma Major Business
2.6.3 Enteris BioPharma Diabetes Therapy and Drug Delivery Product and Solutions
2.6.4 Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Enteris BioPharma Recent Developments and Future Plans
2.7 Dexcom
2.7.1 Dexcom Details
2.7.2 Dexcom Major Business
2.7.3 Dexcom Diabetes Therapy and Drug Delivery Product and Solutions
2.7.4 Dexcom Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Dexcom Recent Developments and Future Plans
2.8 Senseonics Holding
2.8.1 Senseonics Holding Details
2.8.2 Senseonics Holding Major Business
2.8.3 Senseonics Holding Diabetes Therapy and Drug Delivery Product and Solutions
2.8.4 Senseonics Holding Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Senseonics Holding Recent Developments and Future Plans
2.9 Medtech
2.9.1 Medtech Details
2.9.2 Medtech Major Business
2.9.3 Medtech Diabetes Therapy and Drug Delivery Product and Solutions
2.9.4 Medtech Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Medtech Recent Developments and Future Plans
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Diabetes Therapy and Drug Delivery Product and Solutions
2.10.4 Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Johnson & Johnson Recent Developments and Future Plans
2.11 Synertech
2.11.1 Synertech Details
2.11.2 Synertech Major Business
2.11.3 Synertech Diabetes Therapy and Drug Delivery Product and Solutions
2.11.4 Synertech Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Synertech Recent Developments and Future Plans
2.12 Zosano Pharma
2.12.1 Zosano Pharma Details
2.12.2 Zosano Pharma Major Business
2.12.3 Zosano Pharma Diabetes Therapy and Drug Delivery Product and Solutions
2.12.4 Zosano Pharma Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Zosano Pharma Recent Developments and Future Plans
2.13 Relmada Therapeutics
2.13.1 Relmada Therapeutics Details
2.13.2 Relmada Therapeutics Major Business
2.13.3 Relmada Therapeutics Diabetes Therapy and Drug Delivery Product and Solutions
2.13.4 Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Relmada Therapeutics Recent Developments and Future Plans
2.14 Eli Lilly
2.14.1 Eli Lilly Details
2.14.2 Eli Lilly Major Business
2.14.3 Eli Lilly Diabetes Therapy and Drug Delivery Product and Solutions
2.14.4 Eli Lilly Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Eli Lilly Recent Developments and Future Plans
2.15 Transdermal Specialties
2.15.1 Transdermal Specialties Details
2.15.2 Transdermal Specialties Major Business
2.15.3 Transdermal Specialties Diabetes Therapy and Drug Delivery Product and Solutions
2.15.4 Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Transdermal Specialties Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Diabetes Therapy and Drug Delivery Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Diabetes Therapy and Drug Delivery Players Market Share
3.2.2 Top 10 Diabetes Therapy and Drug Delivery Players Market Share
3.2.3 Market Competition Trend
3.3 Diabetes Therapy and Drug Delivery Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Diabetes Therapy and Drug Delivery Revenue and Market Share by Type (2016-2021)
4.2 Global Diabetes Therapy and Drug Delivery Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Diabetes Therapy and Drug Delivery Revenue Market Share by Application (2016-2021)
5.2 Diabetes Therapy and Drug Delivery Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
6.2 North America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
6.3 North America Diabetes Therapy and Drug Delivery Market Size by Country
6.3.1 North America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
6.3.2 United States Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
6.3.3 Canada Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
6.3.4 Mexico Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
7.2 Europe Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
7.3 Europe Diabetes Therapy and Drug Delivery Market Size by Country
7.3.1 Europe Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
7.3.2 Germany Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.3 France Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.5 Russia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
7.3.6 Italy Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
8.2 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
8.3 Asia-Pacific Diabetes Therapy and Drug Delivery Market Size by Region
8.3.1 Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Region (2016-2026)
8.3.2 China Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.3 Japan Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.4 South Korea Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.5 India Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
8.3.7 Australia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
9.2 South America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
9.3 South America Diabetes Therapy and Drug Delivery Market Size by Country
9.3.1 South America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
9.3.2 Brazil Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
9.3.3 Argentina Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Type (2016-2026)
10.2 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Application (2016-2026)
10.3 Middle East & Africa Diabetes Therapy and Drug Delivery Market Size by Country
10.3.1 Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Country (2016-2026)
10.3.2 Turkey Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
10.3.4 UAE Diabetes Therapy and Drug Delivery Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Diabetes Therapy and Drug Delivery Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Diabetes Therapy and Drug Delivery Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Diabetes Therapy and Drug Delivery Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Diabetes Therapy and Drug Delivery Revenue (USD Million) by Region (2016-2021)
Table 5. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Diabetes Therapy and Drug Delivery Product and Solutions
Table 9. Abbott Laboratories Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Medtronic Corporate Information, Head Office, and Major Competitors
Table 11. Medtronic Major Business
Table 12. Medtronic Diabetes Therapy and Drug Delivery Product and Solutions
Table 13. Medtronic Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Sanofi Corporate Information, Head Office, and Major Competitors
Table 15. Sanofi Major Business
Table 16. Sanofi Diabetes Therapy and Drug Delivery Product and Solutions
Table 17. Sanofi Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novo Nordisk Corporate Information, Head Office, and Major Competitors
Table 19. Novo Nordisk Major Business
Table 20. Novo Nordisk Diabetes Therapy and Drug Delivery Product and Solutions
Table 21. Novo Nordisk Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. MannKind Corporate Information, Head Office, and Major Competitors
Table 23. MannKind Major Business
Table 24. MannKind Diabetes Therapy and Drug Delivery Product and Solutions
Table 25. MannKind Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Enteris BioPharma Corporate Information, Head Office, and Major Competitors
Table 27. Enteris BioPharma Major Business
Table 28. Enteris BioPharma Diabetes Therapy and Drug Delivery Product and Solutions
Table 29. Enteris BioPharma Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Dexcom Corporate Information, Head Office, and Major Competitors
Table 31. Dexcom Major Business
Table 32. Dexcom Diabetes Therapy and Drug Delivery Product and Solutions
Table 33. Dexcom Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Senseonics Holding Corporate Information, Head Office, and Major Competitors
Table 35. Senseonics Holding Major Business
Table 36. Senseonics Holding Diabetes Therapy and Drug Delivery Product and Solutions
Table 37. Senseonics Holding Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Medtech Corporate Information, Head Office, and Major Competitors
Table 39. Medtech Major Business
Table 40. Medtech Diabetes Therapy and Drug Delivery Product and Solutions
Table 41. Medtech Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 43. Johnson & Johnson Major Business
Table 44. Johnson & Johnson Diabetes Therapy and Drug Delivery Product and Solutions
Table 45. Johnson & Johnson Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Synertech Corporate Information, Head Office, and Major Competitors
Table 47. Synertech Major Business
Table 48. Synertech Diabetes Therapy and Drug Delivery Product and Solutions
Table 49. Synertech Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Zosano Pharma Corporate Information, Head Office, and Major Competitors
Table 51. Zosano Pharma Major Business
Table 52. Zosano Pharma Diabetes Therapy and Drug Delivery Product and Solutions
Table 53. Zosano Pharma Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Relmada Therapeutics Corporate Information, Head Office, and Major Competitors
Table 55. Relmada Therapeutics Major Business
Table 56. Relmada Therapeutics Diabetes Therapy and Drug Delivery Product and Solutions
Table 57. Relmada Therapeutics Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 59. Eli Lilly Major Business
Table 60. Eli Lilly Diabetes Therapy and Drug Delivery Product and Solutions
Table 61. Eli Lilly Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Transdermal Specialties Corporate Information, Head Office, and Major Competitors
Table 63. Transdermal Specialties Major Business
Table 64. Transdermal Specialties Diabetes Therapy and Drug Delivery Product and Solutions
Table 65. Transdermal Specialties Diabetes Therapy and Drug Delivery Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Diabetes Therapy and Drug Delivery Revenue (USD Million) by Players (2019-2021)
Table 67. Global Diabetes Therapy and Drug Delivery Revenue Share by Players (2019-2021)
Table 68. Breakdown of Diabetes Therapy and Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Diabetes Therapy and Drug Delivery Players Head Office, Products and Services Provided
Table 70. Diabetes Therapy and Drug Delivery Mergers & Acquisitions in the Past Five Years
Table 71. Diabetes Therapy and Drug Delivery New Entrants and Expansion Plans
Table 72. Global Diabetes Therapy and Drug Delivery Revenue (USD Million) by Type (2016-2021)
Table 73. Global Diabetes Therapy and Drug Delivery Revenue Share by Type (2016-2021)
Table 74. Global Diabetes Therapy and Drug Delivery Revenue Forecast by Type (2021-2026)
Table 75. Global Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021)
Table 76. Global Diabetes Therapy and Drug Delivery Revenue Forecast by Application (2021-2026)
Table 77. North America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Diabetes Therapy and Drug Delivery Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Diabetes Therapy and Drug Delivery Picture
Figure 2. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Type in 2020
Figure 3. Inhalable Insulin
Figure 4. Oral Insulin
Figure 5. Insulin Patches
Figure 6. CGM Systems
Figure 7. Artificial Pancreas
Figure 8. Diabetes Therapy and Drug Delivery Revenue Market Share by Application in 2020
Figure 9. Diagnostic/Clinics Picture
Figure 10. ICUs Picture
Figure 11. Home Healthcare Picture
Figure 12. Global Diabetes Therapy and Drug Delivery Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Diabetes Therapy and Drug Delivery Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 15. Global Diabetes Therapy and Drug Delivery Revenue Market Share by Region in 2020
Figure 16. North America Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Diabetes Therapy and Drug Delivery Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Diabetes Therapy and Drug Delivery Market Drivers
Figure 22. Diabetes Therapy and Drug Delivery Market Restraints
Figure 23. Diabetes Therapy and Drug Delivery Market Trends
Figure 24. Abbott Laboratories Recent Developments and Future Plans
Figure 25. Medtronic Recent Developments and Future Plans
Figure 26. Sanofi Recent Developments and Future Plans
Figure 27. Novo Nordisk Recent Developments and Future Plans
Figure 28. MannKind Recent Developments and Future Plans
Figure 29. Enteris BioPharma Recent Developments and Future Plans
Figure 30. Dexcom Recent Developments and Future Plans
Figure 31. Senseonics Holding Recent Developments and Future Plans
Figure 32. Medtech Recent Developments and Future Plans
Figure 33. Johnson & Johnson Recent Developments and Future Plans
Figure 34. Synertech Recent Developments and Future Plans
Figure 35. Zosano Pharma Recent Developments and Future Plans
Figure 36. Relmada Therapeutics Recent Developments and Future Plans
Figure 37. Eli Lilly Recent Developments and Future Plans
Figure 38. Transdermal Specialties Recent Developments and Future Plans
Figure 39. Global Diabetes Therapy and Drug Delivery Revenue Share by Players in 2020
Figure 40. Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 41. Global Top 3 Players Diabetes Therapy and Drug Delivery Revenue Market Share in 2020
Figure 42. Global Top 10 Players Diabetes Therapy and Drug Delivery Revenue Market Share in 2020
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 44. Global Diabetes Therapy and Drug Delivery Revenue Share by Type in 2020
Figure 45. Global Diabetes Therapy and Drug Delivery Market Share Forecast by Type (2021-2026)
Figure 46. Global Diabetes Therapy and Drug Delivery Revenue Share by Application in 2020
Figure 47. Global Diabetes Therapy and Drug Delivery Market Share Forecast by Application (2021-2026)
Figure 48. North America Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)
Figure 49. North America Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)
Figure 50. North America Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 51. United States Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Canada Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Mexico Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Europe Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)
Figure 55. Europe Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)
Figure 56. Europe Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 57. Germany Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. France Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. United Kingdom Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Russia Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Italy Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Asia-Pacific Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)
Figure 63. Asia-Pacific Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Diabetes Therapy and Drug Delivery Revenue Market Share by Region (2016-2026)
Figure 65. China Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Japan Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South Korea Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. India Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Southeast Asia Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Australia Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South America Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)
Figure 72. South America Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)
Figure 73. South America Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 74. Brazil Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East and Africa Diabetes Therapy and Drug Delivery Sales Market Share by Type (2016-2026)
Figure 77. Middle East and Africa Diabetes Therapy and Drug Delivery Sales Market Share by Application (2016-2026)
Figure 78. Middle East and Africa Diabetes Therapy and Drug Delivery Revenue Market Share by Country (2016-2026)
Figure 79. Turkey Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. UAE Diabetes Therapy and Drug Delivery Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界の糖尿病用インスリンデリバリーペン市場 2021：企業別、地域別、種類・用途別 The Diabetes Insulin Delivery Pens market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …- 世界のインスリンデリバリーポンプ市場 2021：企業別、地域別、種類・用途別 The Insulin Delivery Pump market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の自動インスリン送達システム市場 2021：企業別、地域別、種類・用途別 The Automatic Insulin Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の人間インスリンデリバリーシステム市場 2021：企業別、地域別、種類・用途別 The Human Insulin Delivery System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の部位特異的ドラッグデリバリー市場 2021：企業別、地域別、種類・用途別 The Site-Specific Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…